Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjustments in purchasing arrangements to support the COVID-19 health sector response: evidence from eight middle-income countries.
Parmar D, Mathauer I, Bloom D, Dkhimi F, Abuosi AA, Chen D, Chukwuma A, de Claro V, Comsa R, Domingo AF, Doroshenko O, Gong E, Goroshko A, Nketiah-Amponsah E, Lylozian H, Nkangu M, Onwujekwe O, Obikeze O, Pattnaik A, Rivillas JC, Tapkigen J, Vîlcu I, Wang H, Wee Co PA. Parmar D, et al. Among authors: doroshenko o. Health Policy Plan. 2024 Feb 22;39(2):213-223. doi: 10.1093/heapol/czad121. Health Policy Plan. 2024. PMID: 38261999 Free PMC article.
Impact of a sugar-sweetened beverage tax on sugar producers in Ukraine.
Mandeville KL, Nivievskyi O, Neyter R, Martyshev P, Vakhitov V, Warren B, Doroshenko O. Mandeville KL, et al. Among authors: doroshenko o. Eur J Public Health. 2023 Aug 1;33(4):665-667. doi: 10.1093/eurpub/ckad083. Eur J Public Health. 2023. PMID: 37203262 Free PMC article.
Impact of the COVID-19 pandemic on Ukrainian mortality, 2020-2021.
Mehta NK, Honchar I, Doroshenko O, Pak K, Daniuk M, Polikarchuk P. Mehta NK, et al. Among authors: doroshenko o. PLoS One. 2023 May 19;18(5):e0285950. doi: 10.1371/journal.pone.0285950. eCollection 2023. PLoS One. 2023. PMID: 37205657 Free PMC article.
Diabetes care cascade in Ukraine: an analysis of breakpoints and opportunities for improved diabetes outcomes.
Stuart RM, Khan O, Abeysuriya R, Kryvchun T, Lysak V, Bredikhina A, Durdykulyieva N, Mykhailets V, Kaidashova E, Doroshenko O, Shubber Z, Wilson D, Zhao F, Fraser-Hurt N. Stuart RM, et al. Among authors: doroshenko o. BMC Health Serv Res. 2020 May 11;20(1):409. doi: 10.1186/s12913-020-05261-y. BMC Health Serv Res. 2020. PMID: 32393341 Free PMC article.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
23 results